-
2023-508962-14-00
5
2020-06-18
Relapsed/Refractory Multiple Myeloma
-
2023-508292-37-00
5
2020-03-06
Cardiovascular Disease
-
2023-509908-15-00
10
2020-01-20
Mantle Cell Lymphoma
-
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
-
2023-504932-16-00
5
2019-06-04
Muscle Invasive Bladder Cancer
-
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
-
2023-510015-19-00
5
2019-02-11
Patients with histologically or cytologically documented muscle-invasi
-
2023-505495-30-00
5
2019-02-01
Immunoglobulin A Nephropathy (IgAN)
-
2023-507906-15-00
5
2019-01-30
Relapsing multiple sclerosis (RMS)
-
2024-510605-28-00
5
2018-11-27
Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer
-
2022-501076-26-00
4
2018-08-28
high risk diffuse large B-cell lymphoma
-
2023-508018-41-00
4
2018-07-27
Primary Myelofibrosis (PMF), Post-polycythemia Vera or Post-essential
-
2022-502798-40-00
5
2017-07-31
Patients with resected colon carcinoma
-
2023-509671-17-00
5
2017-07-12
Breast Cancer
-
2024-516106-31-00
10
2017-06-16
Early stage colorectal cancer
-
2024-511348-25-00
10
2015-12-11
Myelodysplastic syndromes (MDS)
-
2023-509348-84-00
5
2015-04-27
Chronic Lymphocytic Leukemia
-
2023-507220-23-00
5
2024-07-26
Transthyretin Amyloidosis with Cardiomyopathy
-
2024-511112-24-00
4
2025-01-17
Narcolepsy Type 1
-
2024-511057-22-00
5
2024-12-04
Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia
-
2023-508736-62-00
4
2024-08-08
Heart failure (HF) with reduced ejection fraction (HFrEF)
-
2023-508737-13-00
4
2024-08-08
chronic heart failure
-
2023-507942-10-00
4
2024-07-31
Major depressive disorder
-
2023-505893-14-00
5
2024-06-04
Progressive Supranuclear Palsy